Overview Experience Events News Intelligence Courtenay C. Brinckerhoff Partner cbrinckerhoff foley.com Download vCard Sale of IP Assets for Nabi Biopharmaceuticals Handled the intellectual property aspects of a $46 million deal between our client, Nabi Biopharmaceuticals, and GlaxoSmithKline, relating to the sale of a vaccine... IP and Regulatory Matters for International Pharmaceutical Company Defended BHR Pharma, LLC's main pharmaceutical product against multiple generic competitors, in ANDA litigation, and related measures. Worked with principals to... ApoImmune Inc. Patent for ApoVax Technology Represented ApoImmune Inc. in obtaining a U.S. patent covering its ApoVax technology and corresponding patents worldwide. In April 2009, ApoImmune was selected as... Related 1 2 3
Sale of IP Assets for Nabi Biopharmaceuticals Handled the intellectual property aspects of a $46 million deal between our client, Nabi Biopharmaceuticals, and GlaxoSmithKline, relating to the sale of a vaccine...
IP and Regulatory Matters for International Pharmaceutical Company Defended BHR Pharma, LLC's main pharmaceutical product against multiple generic competitors, in ANDA litigation, and related measures. Worked with principals to...
ApoImmune Inc. Patent for ApoVax Technology Represented ApoImmune Inc. in obtaining a U.S. patent covering its ApoVax technology and corresponding patents worldwide. In April 2009, ApoImmune was selected as...